Furthermore, treatment of Alzheimer's disease transgenic mice (dual transgenic expressing mutant forms of both App and Psen1 genes) with phenylbutyrate resulted in a reduction of amyloid plaques in the cortex and hippocampus (Wiley et al, 2011). Here, APP is linked to early-onset autosomal dominant Alzheimer disease.